4th Inflammasome Therapeutics Summit
Evvnt Promotion / evvnt
Archiv
29.11.2022 - 01.12.2022 Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 to 16:30
Kongressthemen
The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R and D landscape.
The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R and D landscape.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1252816-3?pid=4832
Speakers: Alan Watt, Chief Scientific Officer, NodThera, Bruno Reversade, Professor and Director, Laboratory of Human Genetics and Therapeutics GIS and IMCB, A*STAR, and more.
Brochure: https://go.evvnt.com/1252816-3?pid=4832
Speakers: Alan Watt, Chief Scientific Officer, NodThera, Bruno Reversade, Professor and Director, Laboratory of Human Genetics and Therapeutics GIS and IMCB, A*STAR, and more.
Anfragen und Anmeldung:
https://go.evvnt.com/1252816-2?pid=4832
Frau Jessica Durston
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 2199.00 - USD 5696.00
USD 2199.00 - USD 5696.00
Teilnehmer erwartet
1000 - 1000
1000 - 1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
